Intervention
Isoniazid
ClinicalTrials.gov intervention label
Clinical trials
30 shownA Trial of Stratified Patient-Centered Treatment Regimens for Active TB (SPECTRA-TB)NCT07595042 · 2026-10-30
NOT_YET_RECRUITINGA Study of Daily Rifapentine Combined With Isoniazid (1HP) for Tuberculosis Prevention in Children Less Than 13 Years of Age With and Without HIVNCT07124559 · 2026-10-15
NOT_YET_RECRUITINGAn Adaptive Multi-arm Trial to Improve Clinical Outcomes Among Children Recovering From Complicated SAMNCT05994742 · 2024-07-15
COMPLETEDSafety and Tolerability of 1 Month Daily (1HP) and 3 Months Weekly (3HP) Isoniazid and Rifapentine With Pharmacokinetics of Dolutegravir (DTG) in Pregnant People With HIVNCT05122026 · 2024-01-17
ACTIVE_NOT_RECRUITINGSafety and Tolerability of Metformin in People With Tuberculosis (TB) and Human Immunodeficiency Virus (HIV)NCT04930744 · 2022-03-04
COMPLETEDClofazimine- and Rifapentine-Containing Treatment Shortening Regimens in Drug-Susceptible Tuberculosis: The CLO-FAST StudyNCT04311502 · 2021-11-05
TERMINATEDTuberculosis Clinical Trials Consortium Study 35NCT03730181 · 2019-11-12
COMPLETEDAddiction, HIV and Tuberculosis in Malaysian Criminal Justice SettingsNCT03089983 · 2017-08-21
COMPLETEDEvaluation of the Effect of 3HP vs Periodic 3HP vs 6H in HIV-Positive IndividualsNCT02980016 · 2016-11-01
COMPLETEDInfant TB Infection Prevention StudyNCT02613169 · 2016-08-01
COMPLETEDRifampin-Based Tuberculosis Treatment Versus Rifabutin-Based Tuberculosis Treatment in Persons With HIVNCT01601626 · 2013-07-13
TERMINATEDReduction of EArly mortaLITY in HIV-infected Adults and Children Starting Antiretroviral TherapyNCT01825031 · 2013-06-01
COMPLETEDREMEMBER: Reducing Early Mortality & Morbidity by Empiric Tuberculosis (TB) TreatmentNCT01380080 · 2011-10-01
COMPLETEDStudy of Pre-clearance of Latent Tuberculosis Infection And BCG RevaccinationNCT01119521 · 2010-10-01
COMPLETEDDiagnosis and Treatment of Co-infection With Human Immunodeficiency Virus /Latent Tuberculosis Infection (HIV/TBL)NCT01875952 · 2010-05-01
UNKNOWNStudy of Limited Versus Continuous Isoniazid Tuberculosis Preventive Therapy in HIV-infected Persons in BotswanaNCT00164281 · 2004-11-01
COMPLETEDEarly Bactericidal Activity of Linezolid, Gatifloxacin, Levofloxacin, Isoniazid (INH) and Moxifloxacin in HIV Negative Adults With Initial Episodes of Sputum Smear-Positive Pulmonary TuberculosisNCT00396084 · 2004-02-10
COMPLETEDIsoniazid Prophylaxis With Concomitant Cotrimoxazole in HIV-infected ChildrenNCT00330304 · 2003-01-01
COMPLETEDTuberculosis Prevention for HIV Infected AdultsNCT00057122 · 2002-09-01
COMPLETEDTuberculosis Treatment Shortening TrialNCT00130247 · 2002-04-08
COMPLETEDTBTC Study 25PK: Intensive Pharmacokinetic Study of Three Doses of Rifapentine and 25-Desacetyl RifapentineNCT00023387 · 2000-03-01
COMPLETEDTBTC Study 23A: Pharmacokinetics of Intermittent Isoniazid and Rifabutin in HIV-TBNCT00023348 · 1999-07-01
COMPLETEDPreventive Treatment Against Tuberculosis (TB) in Patients With Human Immunodeficiency Virus (HIV) Infection and Confirmed Latent Tuberculous InfectionNCT00000638
COMPLETEDProphylaxis Against Tuberculosis (TB) in Patients With Human Immunodeficiency Virus (HIV) Infection and Confirmed Latent Tuberculous InfectionNCT00000636
COMPLETEDA Prospective Study of Multidrug Resistance and a Pilot Study of the Safety of and Clinical and Microbiologic Response to Levofloxacin in Combination With Other Antimycobacterial Drugs for Treatment of Multidrug-Resistant Pulmonary Tuberculosis (MDRTB) in HIV-Infected Patients.NCT00000796
COMPLETEDProphylaxis Against Tuberculosis (TB) in Patients With Human Immunodeficiency Virus (HIV) Infection and Suspected Latent Tuberculous InfectionNCT00000959
COMPLETEDMetabolism of Antituberculosis Drugs in HIV-Infected Persons With TuberculosisNCT00000950
COMPLETEDEffectiveness of Anti-HIV Therapy (HAART) in HIV-Infected Patients With TuberculosisNCT00004736
COMPLETEDA Pilot Study of Methodology to Rapidly Evaluate Drugs for Bactericidal Activity, Tolerance, and Pharmacokinetics in the Treatment of Pulmonary Tuberculosis Using Isoniazid and LevofloxacinNCT00000778
COMPLETEDThe Treatment of Tuberculosis in HIV-Infected PatientsNCT00001033
COMPLETEDCommon conditions
Tuberculosis24HIV Infections11HIV3HIV Infection2Addiction1Child Malnutrition1Comorbidities and Coexisting Conditions1Hepatitis1HIV Coinfection1HIV Seropositivity1HIV/AIDS1Human Immunodeficiency Virus1Human Immunodeficiency Virus (HIV)1Latent Tuberculosis1Latent Tuberculosis Infection (LTI)1Opioid Dependence1Pregnancy1Pulmonary Tuberculosis1Severe Acute Malnutrition1Tuberculosis (TB)1Tuberculosis Infection1
Leading sponsors
National Institute of Allergy and Infectious Diseases (NIAID)15Centers for Disease Control and Prevention4Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections2The Aurum Institute NPC2Anna Griffiths, MRC1Instituto Nacional de Salud Publica, Mexico1Queen Mary University of London1University of Cape Town1University of Massachusetts, Worcester1University of Washington1Yale University1
Trial status mix
COMPLETED24
NOT_YET_RECRUITING2
TERMINATED2
ACTIVE_NOT_RECRUITING1
UNKNOWN1
Phase mix
PHASE210
PHASE38
NA7
PHASE17
PHASE43
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.